Medicine, Cardiology Division

Grants

Grants per year 1999 2014 2015 2016 2017 2018 2019 2020 2021 2022 2031

• 238 Active
• 600 Finished

Grants per year

Search results

• Research project

  LUX-Dx Heart Failure Sensors in an Insertable Cardiac Monitor System Clinical Study

  Okwuosa, I. S.

  Boston Scientific Corporation

  1/19/22 → 1/19/24

  Project: Research project

• Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab

  Ghafourian, K.

  Massachusetts General Hospital, National Institute of Allergy and Infectious Diseases

  5/15/20 → 4/30/23

  Project: Research project

• Prot#MDT16028: EV-ICD: ExtraVascular Implantable Cardioverter Defibrillator Pivotal Study

  Lin, A. C.

  Medtronic, Inc.

  3/16/20 → 3/16/23

  Project: Research project

• Protocol # PR‐2053:The Jewel IDE Study: A Clinical Evaluation of the JEWEL P-WCD in Subjects at High Risk for Sudden Cardiac Arrest (JEWEL)

  Patil, K. D.

  Element Science, Inc.

  8/16/22 → 8/16/25

  Project: Research project

• Prot#D1690C00078: A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients with Heart Failure with Reduced Ejection Fraction Who Ha

  Tibrewala, A.

  TIMI Study Group, AstraZeneca Pharmaceuticals LP

  2/18/21 → 2/18/24

  Project: Research project

• Cardiology Division's Interventional Fellowship Program

  Schimmel, D. R.

  Edwards Lifesciences LLC

  7/1/22 → 6/30/23

  Project: Research project

  • interventions 100%
  • angiography 66%
  • heart disease 33%
  • coronaries 33%
  • Coronary Angiography 33%

• Abbott Fund Fellowship for Interventional Cardiology

  Schimmel, D. R.

  Abbott Fund

  7/1/20 → 6/30/21

  Project: Research project

  • Interventional Cardiology 100%
  • Fellowships 100%

• Interventional Cardiology Fellowship MDT210015640 FY21-22

  Schimmel, D. R.

  Medtronic, Inc.

  7/1/21 → 6/30/22

  Project: Research project

  • Interventional Cardiology 100%

• Prot# DS1040-B-U107: A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multi- Center, Single Ascending Dose Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of DS-1040b when Added to Standard of Care Anticoagulati

  Schimmel, D. R.

  Daiichi Sankyo, Inc.

  10/10/17 → 10/10/20

  Project: Research project

• Prot# 18-002: FLowTriever All-Comer Registry for Patient Safety and Hemodynamics

  Schimmel, D. R.

  Inari Medical, Inc

  5/13/21 → 5/13/24

  Project: Research project

• The pathogenic mechanism of anti-phosphatidylethanolamine antibodies

  Cook-Mills, J. M., Zhao, M. & Folsch, H.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  7/12/18 → 6/30/20

  Project: Research project

  • Phosphatidylethanolamine 100%
  • antibodies 38%
  • Monospecific Antibody 38%
  • inflammation 11%
  • membranes 11%

• American Heart Association SURE Award Jessica Guzman

  Okwuosa, I. S. & Ding, Y.

  American Heart Association

  6/1/22 → 8/31/22

  Project: Research project

  • Research 100%
  • Associations 100%
  • Experience 100%
  • Heart 100%
  • Americans 100%

• Mastery Learning Right Heart Catheterization Simulation Program for Trainee Education

  Sweis, R. N.

  Northwestern Memorial Hospital

  9/1/16 → 8/31/18

  Project: Research project

  • simulation 100%
  • learning 100%
  • Learning 100%
  • waveforms 66%
  • Cardiac Catheterization 66%

• Ethanol Effects on SR Ca²+ Release in Cardiac Myocytes

  Wasserstrom, J. A. & Aistrup, G. L.

  National Institute on Alcohol Abuse and Alcoholism

  8/1/03 → 7/31/06

  Project: Research project

  • sarcoplasmic reticulum 100%
  • Sarcoplasmic reticulum 100%
  • contraction 60%
  • alcohols 50%
  • excitation 40%

• Wrist Worn Blood Pressure Measurement: Accuracy of Non-Invasive Non-Oscillometric Blood Pressure Wrist Worn Measurement

  Vorovich, E. E.

  LiveMetric (Medical) S.A.

  4/3/19 → 4/3/22

  Project: Research project

• DEFINITY 416: A Phase IV, Open-Label Safety Evaluation of the Effect of DEFINITY on Pulmonary Artery Hemodynamics in Patients with Normal and Increased Pulmonary Artery Pressure

  Mikati, I. A.

  Lantheus Medical Imaging, Inc.

  8/6/09 → 8/5/12

  Project: Research project

• Prot# NEB-MD-06: Efficacy and Tolerability of Nebivolol Compared with Carvedilol in Patients with Coronary Artery Disease and Stage I or II Hypertension

  Mikati, I. A.

  Forest Laboratories, Inc

  9/15/08 → 9/15/11

  Project: Research project

• Prot#CV013020:A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients with Heart Failure and Impaired Systolic Function

  Vorovich, E. E.

  PPD Investigator Services, LLC, Bristol-Myers Squibb Company

  7/13/18 → 7/13/21

  Project: Research project

• Prot# DMP 115-415: CARES (Contrast EchocArdiography Registry for Safety Surveillance): A Prospective, Phase IV, Open-Label, NonRandomized, Multicenter, Surveillance Registry Study to Evaluate the Safety of Definity in Clinical Practice

  Mikati, I. A.

  Bristol-Myers Squibb Company

  4/1/08 → 4/1/11

  Project: Research project

• ROMICAT II Biomarker Substudy: Rule Out Myocardial Infarction/Ischemia Using Computer Assisted Tomography

  Mikati, I. A.

  Massachusetts General Hospital, American College of Radiology Imaging Network

  5/1/11 → 4/30/12

  Project: Research project

• Prot# SN-C-00003: Outcomes AlloMap Registry (OAR) study and sub study: Utility of Donor-Derived Cell-free DNA in Association with Gene-Expression Profiling (AlloMap) in Heart Transplant Recipients (D-OAR)

  Vorovich, E. E.

  CareDx, Inc.

  8/10/16 → 8/10/19

  Project: Research project

• Prot# P04737: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease: Thrombin Receptor Antagonist in Second

  Fintel, D. J.

  Schering-Plough Research Institute

  9/15/08 → 9/15/14

  Project: Research project

• Prot# 4522US/0011: Rndomzd, Dbl-Bld, Placebo-Controlled, Multicenter, Phase III Study of Rosuvastatin (Crestor®) 20mg in Primary Prevention of Cardiovascular Events Among Subjects w/ Low Levels of LDL-Cholesterol & Elevated Levels of C-Reactive Protein

  Fintel, D. J.

  PPD Development, AstraZeneca Pharmaceuticals LP

  7/22/03 → 5/27/10

  Project: Research project

• CCLR325X2202: A Randomized, Subject and Investigator-Blind, Placebo Controlled Study of CLR325 in Chronic Stable Heart Failure Patients

  Wilcox, J. E.

  Novartis Pharmaceuticals Corporation

  10/1/15 → 8/31/19

  Project: Research project

• Prot#MYK-491-006: An Open-Label, Exploratory Study of the Safety and Preliminary Efficacy of Danicamtiv in Stable Ambulatory Patients with Primary Dilated Cardiomyopathy due to either MYH7 or TTN Variants

  Wilcox, J. E.

  Medpace Clinical Research LLC, MyoKardia, Inc.

  8/31/21 → 8/31/24

  Project: Research project